Ngai Na Co, PhD

Dr. Co is currently a postdoctoral fellow in the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas MD Anderson Cancer Center. She obtained her Ph.D. degree at the Chinese University of Hong Kong in 2009 during which she investigated the function of a novel oncogene AF1q in human cancer cells. Her research interests include understanding the molecular mechanism underlying obesity on gynecologic tumor risk, the communication between ovarian cancer cells and their microenvironment through microvesicle exchange, and the functional roles of stromal cells on modulating ovarian tumor progression. She is the recipient of the Scholar-in-Training Award from the American Association of Cancer Research in 2011 and 2012.